Archean Chemical Industries Ltd
Archean Chemical Industries Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
The company aims to increase elemental bromine production to north of 18,000 tons next year, with a medium-term target to reach a run rate between 18,000 and 25,000 tons. The company expects volume growth to continue, especially driven by marine chemicals and derivatives businesses.
From Archean Chemical Industries Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- The company aims to increase elemental bromine production to north of 18,000 tons next year, with a medium-term target to reach a run rate between 18,000 and 25,000 tons.
- Plans for brownfield expansion to raise capacity from 25,000 tons towards 40,000 tons, aligned with growth in the derivatives business.
- Bromine derivative (Acume) plant utilization targeted to scale up from current 30-40% to around 60-70% during FY 2026-27, supported by expanded product portfolio and accelerated customer acceptance.
- Industrial salt volumes are growing steadily with volumes reverting back to over 1 million tons quarterly, supporting stable revenue.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Archean Chemical Industries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Archean Chemical Industries is progressing with its semiconductor business initiative (SiCSem), approved under the Indian Semiconductor Mission. Execution is underway on a 25-acre site in Bhubaneshwar with site allotment, groundbreaking, land leveling, and ongoing surveys. The finalization of the fiscal support agreement with the Indian Semiconductor Mission is in progress.
- The company is evaluating a flame retardant bromine project; currently in the project evaluation phase with a focus on feasibility and scaling.
- Continued investment in developing the go-to-market strategy and finalizing supply partners for semiconductor fab design, EPC, and project execution.
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Archean Chemical Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Current order backlog for elemental bromine is around 6,500 tons (not derivatives).
- This backlog is spread across various geographies and industries with no single dominant factor.
- The orders have staggered delivery schedules over a longer period, not meant for immediate dispatch.
- The company maintains a balance between short-term and long-term contracts within this orderbook.
- Majority of orders are focused on Asian markets, particularly Asia Pacific.
- Specific industry details for the order volumes were not provided; the company requested inquiries to be sent to Investor Relations for detailed info.
2 more points management made on order book & pipeline
Archean Chemical Industries Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹301 Cr, net profit ₹12 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Archean Chemical's management said in earlier quarters
- Q1 FY26 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q4 FY25 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q2 FY26 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
Others in Chemicals & Petrochemicals this season
- Balaji Amines Ltd (Q3 FY26)
Revenue from Operations for Q3FY26: ₹331.30 crore, compared to ₹320.59 crore in Q3FY25 (consolidated) and ₹304.68 crore in Q3FY25 (standalone). Key concall…
- Vidhi Specialty Food Ingredients Ltd (Q3 FY26)
94.5 Cr, down 4.1% YoY from Rs. Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
- Bodal Chemicals Ltd (Q3 FY26)
5,046.6 Mn, up 13.3% YoY (Q3 FY25: Rs. Key concall takeaways from Bodal Chemicals Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
- Chemcon Speciality Chemicals Ltd (Q3 FY26)
Q3 FY26 Revenue from Operations:** ₹57.3 Cr (vs ₹54.4 Cr in Q3 FY25) — approx. Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q3 FY26 earnings…
Frequently Asked Questions
What were Archean Chemical Industries Ltd Q3 FY26 results?
The company aims to increase elemental bromine production to north of 18,000 tons next year, with a medium-term target to reach a run rate between 18,000 and 25,000 tons. The company expects volume growth to continue, especially driven by marine chemicals and derivatives businesses.
What is Archean Chemical Industries Ltd share price analysis?
Archean Chemical Industries Ltd currently shows a neutral. The stock trades at a P/E of 66.8 with a market cap of ₹6,467 Cr. Investors should review the full earnings analysis for detailed insights.
Is Archean Chemical Industries Ltd planning capital expenditure?
Archean Chemical Industries is progressing with its semiconductor business initiative (SiCSem), approved under the Indian Semiconductor Mission.
Keep Archean Chemical Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.